We are live on ! Find out more
IMMU

Immunomedics Inc
IMMU

Delisted

IMMU was delisted on the 22nd of October, 2020.

85 hedge funds and large institutions have $166M invested in Immunomedics Inc in 2015 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 36 increasing their positions, 16 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 16

17% more call options, than puts

Call options by funds: $15.2M | Put options by funds: $12.9M

9% more capital invested

Capital invested by funds: $153M → $166M (+$13.1M)

7% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 14

1% less funds holding

Funds holding: 8685 (-1)

Holders
85
Holders Change
-1
Holders Change %
-1.16%
% of All Funds
2.29%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
13
Increased
36
Reduced
16
Closed
14
Calls
$15.2M
Puts
$12.9M
Net Calls
+$2.24M
Net Calls Change
-$940K
Name Holding Trade Value Shares
Change
Change in
Stake
SW
26
SVB Wealth
Massachusetts
$792K
Wells Fargo
27
Wells Fargo
California
$791K +$311K +76,110 +64%
California State Teachers Retirement System (CalSTRS)
28
California State Teachers Retirement System (CalSTRS)
California
$715K +$103K +25,266 +17%
TA
29
Teachers Advisors
New York
$643K +$81.2K +19,872 +14%
Connor, Clark & Lunn Investment Management (CC&L)
30
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$615K -$34.8K -8,500 -5%
California Public Employees Retirement System
31
California Public Employees Retirement System
California
$607K
Barclays
32
Barclays
United Kingdom
$598K +$67.4K +16,485 +12%
CS
33
Credit Suisse
Switzerland
$589K +$112K +27,493 +23%
Morgan Stanley
34
Morgan Stanley
New York
$532K +$245K +59,872 +84%
AIG
35
American International Group
New York
$486K +$276K +67,630 +130%
AllianceBernstein
36
AllianceBernstein
Tennessee
$460K
Swiss National Bank
37
Swiss National Bank
Switzerland
$389K
New York State Common Retirement Fund
38
New York State Common Retirement Fund
New York
$387K +$390K +95,392 New
State Board of Administration of Florida Retirement System
39
State Board of Administration of Florida Retirement System
Florida
$378K
OC
40
Oppenheimer & Co
New York
$377K -$148K -36,178 -28%
RhumbLine Advisers
41
RhumbLine Advisers
Massachusetts
$355K +$7.38K +1,805 +2%
ProShare Advisors
42
ProShare Advisors
Maryland
$353K -$17.9K -4,366 -5%
Goldman Sachs
43
Goldman Sachs
New York
$312K +$127K +31,140 +68%
NV
44
Nair Vinay
$306K +$154K +37,713 +100%
AIM
45
Ada Investment Management
New York
$306K +$308K +75,434 New
BA
46
BlackRock Advisors
Delaware
$268K +$31.4K +7,682 +13%
NFA
47
Nationwide Fund Advisors
Ohio
$253K +$9.07K +2,219 +4%
VOYA Investment Management
48
VOYA Investment Management
Georgia
$250K
MLICM
49
Metropolitan Life Insurance Company (MetLife)
New York
$229K -$21.4K -5,231 -8%
HighTower Advisors
50
HighTower Advisors
Illinois
$206K +$208K +50,765 New

IMMU Hedge Fund Activity: Q2 2015 in Review

85 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q2 2015, worth a combined $166M — up 8.6% from $153M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of IMMU and 13 opened new positions — a net loss of 1 holder — while 16 trimmed existing stakes and 36 added.

The largest buyer was Perceptive Advisors, opening a new position worth an estimated $2.45M. The largest seller was Tekla Capital Management, exiting entirely with an estimated $1.92M sold.

  • 85 institutional investors held Immunomedics Inc (IMMU) as of Q2 2015, down from 86 in Q1 2015.
  • Funds reported $166M of Immunomedics Inc stock for Q2 2015, up 8.6% quarter-over-quarter.
  • 13 funds opened new Immunomedics Inc positions in Q2 2015 and 14 closed out, a net change of -1 holder.
  • The largest Immunomedics Inc buyer in Q2 2015 was Perceptive Advisors, an estimated $2.45M added.
  • The largest Immunomedics Inc seller in Q2 2015 was Tekla Capital Management, an estimated $1.92M sold.

Based on aggregated 13F filings for Q2 2015.